Magellan Health Reports First Quarter 2016 Financial Results

Go back to Magellan Health Reports First Quarter 2016 Financial Results

Magellan Health Services (MGLN) PT Raised to $83 at Jefferies Post Q1

May 6, 2016 8:09 AM EDT

Jefferies analyst David Styblo reiterated a Buy rating and boosted his price target on Magellan Health Services (NASDAQ: MGLN) to $83.00 (from $77.00) following Q1 results.

Styblo commented, "MGLN's PBM business continues to build momentum as it secures new wins and drives... More

Magellan Health (MGLN) Misses Q1 EPS by 1c; Updates EPS Outlook

May 5, 2016 9:21 AM EDT

Magellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.54, $0.01 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Magellan Health sees FY2016 EPS of $3.19-$3.96, versus the consensus of... More